These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29630786)

  • 1. Exploring the use of economic evidence to inform investment in disease prevention - a qualitative study.
    Liu H; Muhunthan J; Ananthapavan J; Hawe P; Shiell A; Jan S
    Aust N Z J Public Health; 2018 Apr; 42(2):200-206. PubMed ID: 29630786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-benefit analysis framework for preventive health interventions to aid decision-making in Australian governments.
    Ananthapavan J; Moodie M; Milat A; Veerman L; Whittaker E; Carter R
    Health Res Policy Syst; 2021 Dec; 19(1):147. PubMed ID: 34923970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What will it take to improve prevention of chronic diseases in Australia? A case study of two national approaches.
    Wutzke S; Morrice E; Benton M; Wilson A
    Aust Health Rev; 2017 May; 41(2):176-181. PubMed ID: 27305656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive health resource allocation decision-making processes and the use of economic evidence in an Australian state government-A mixed methods study.
    Ananthapavan J; Sacks G; Moodie M; Nguyen P; Carter R
    PLoS One; 2022; 17(9):e0274869. PubMed ID: 36121814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the role of economics in prioritization in public health: what do stakeholders think?
    Phillips CJ; Fordham R; Marsh K; Bertranou E; Davies S; Hale J; Kingsley M; Parke S; Porteous C; Rance J; Warm D
    Eur J Public Health; 2011 Oct; 21(5):578-84. PubMed ID: 20817687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organizational determinants of evaluation practice in Australian prevention agencies.
    Schwarzman J; Bauman A; Gabbe B; Rissel C; Shilton T; Smith BJ
    Health Educ Res; 2018 Jun; 33(3):243-255. PubMed ID: 29746649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study.
    Chen LC; Ashcroft DM; Elliott RA
    Pharm World Sci; 2007 Dec; 29(6):661-70. PubMed ID: 17566869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed-method approaches to strengthen economic evaluations in implementation research.
    Dopp AR; Mundey P; Beasley LO; Silovsky JF; Eisenberg D
    Implement Sci; 2019 Jan; 14(1):2. PubMed ID: 30635001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of future skin cancer prevention in Australia.
    Shih ST; Carter R; Heward S; Sinclair C
    Prev Med; 2017 Jun; 99():7-12. PubMed ID: 28131778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
    Knobler S; Bok K; Gellin B
    Vaccine; 2017 Jan; 35 Suppl 1():A43-A45. PubMed ID: 28017435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Studies on Non-Communicable Diseases and Injuries in India: A Systematic Review.
    Gupta I; Roy A
    Appl Health Econ Health Policy; 2018 Jun; 16(3):303-315. PubMed ID: 29611047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economics of prevention: the public health research agenda.
    Chattopadhyay SK; Carande-Kulis VG
    J Public Health Manag Pract; 2004; 10(5):467-71. PubMed ID: 15552773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer screening and health system resilience: keys to protecting and bolstering preventive services during a financial crisis.
    Martin-Moreno JM; Anttila A; von Karsa L; Alfonso-Sanchez JL; Gorgojo L
    Eur J Cancer; 2012 Sep; 48(14):2212-8. PubMed ID: 22424881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of pharmacogenomics: a value-based approach to pragmatic decision making in the face of complexity.
    Snyder SR; Mitropoulou C; Patrinos GP; Williams MS
    Public Health Genomics; 2014; 17(5-6):256-64. PubMed ID: 25278172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do government health departments in Australia access health economics advice to inform decisions for health? A survey.
    Madden L; King L; Shiell A
    Aust New Zealand Health Policy; 2009 Apr; 6():6. PubMed ID: 19358711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten clinician-driven strategies for maximising value of Australian health care.
    Scott I
    Aust Health Rev; 2014 May; 38(2):125-33. PubMed ID: 24820956
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.